phase 4
ii 2
study 3
belinostat 1
pxd 1
relapsed 2
refractory 2
aggressive 3
bcell 4
lymphomas 1
swog 5
s 3
ibritumomab 1
consolidation 2
cycles 1
chop 2
plus 1
radiotherapy 1
highrisk 1
limitedstage 1
lymphoma 7
imexon 1
prooxidant 1
molecule 1
nonhodgkin 1
rchop 1
iodine 1
tositumomab 1
advanced 1
stage 2
diffuse 1
large 1
dlbcl 1
comparative 1
analysis 3
prognostic 1
factor 1
models 1
follicular 2
based 1
iii 1
trial 2
choprituximab 1
versus 1
iodinetositumomab 1
multicenter 1
hypercvad 1
mtxarac 1
rituximab 1
patients 2
previously 1
untreated 1
mantle 1
cell 1
effectiveness 1
firstline 1
management 1
strategies 1
national 1
lymphocare 1
natural 1
history 1
cns 1
relapse 1
nonhodgkins 1
followup 1
southwest 1
oncology 1
group 1
